$57.66 - RAPT | RAPT Therapeutics, Inc. Common Stock

RAPT Therapeutics, Inc. Common Stock (RAPT)

RAPT Therapeutics, Inc. Common Stock

XNAS:RAPT

57.66

0.03%

Ask

$57.66 - 1,100.00

Bid

$57.65 - 12,387.00

Low

$57.63

High

$57.67

Open

$57.67

Prev Close

$57.64

52W High

57.71

52W Low

5.67

Volume

562734

Avg Vol (3m)

3828663.4

Float

17886249.8

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Pharmaceuticals: Major

Date Listed: 08/01/2019

Primary Exchange: XNAS

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Phone: (650) 489-9000

Address: 561 Eccles Avenue

City: South San Francisco

State: CA

Postal Code: 94080

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-5.210000

P/B (TTM)

6.392700

Round Lot

100

Composit FIGI

BBG00PGK50M2

Share Class FIGI

BBG00PGK50N1

Share Class Shares Outstanding

16.54M

Weighted Shares Outstanding

27.71M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion